A series of personal injury suits filed in Los Angeles earlier this month alleges that a charity established by the financier Michael Milken, in conjunction with prostate cancer researchers nationwide, engaged in systematic promotion of PC-Spes, a “nutraceutical” that was sold as a mixture of Chinese herbs, but was laced with prescription drugs.
Also in this 12-page issue: ASCO urges freeze of Medicare payments for chemotherapy at 2004 levels for next two years.
NCI director creates four new deputy director positions to manage the Institute.
Five NCAB members complete terms.
Breast surgeon and advocate Susan Love weds surgeon Helen Cooksey in San Francisco.
Funding opportunities listed.
NIH Director Zerhouni to discuss Roadmap initiatives Feb. 27.
Trending Stories
- Beyond the $500B Stargate Project: The frontier of AI in oncology beckons
- What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - Trump 2016: A look back at the 45th president’s impact on oncology
- FDA grants Cytotron Breakthrough Device Designation for breast, liver and pancreatic cancers
- Felix Feng, GU cancer researcher who made fundamental discoveries in genomics, dies at 48
- Pediatric cancer research cut from spending legislation at last minute
Republicans quietly removed hard-won pediatric cancer bills
